Related Experiment Video
Updated: May 28, 2026

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
Published on: April 28, 2013
Serum and urinary biomarkers in acute kidney transplant rejection
1The Johns Hopkins University School of Medicine, Department of Medicine, Division of Nephrology, Baltimore, MD 21205, USA. nalachk1@jhmi.edu
Background:
Acute rejection (AR) is a common medical problem among kidney transplant recipients, which may cause a significant impact on patients' and allografts' survival. Kidney allograft biopsy remains the "gold standard" for assessing the cause of kidney transplant dysfunction. However, there are limitations for the allograft biopsy; these include the risk of bleeding, injury to the adjacent organs, and the possibility of sampling error leading to misdiagnosis.
Methods:
We conducted a comprehensive review of the literature and main published data that discussed the most relevant serum and urine biomarkers in acute allograft dysfunction, along with their clinical significance.
Results:
There have been significant discoveries of several important biomarkers that correlated with biopsy findings, clinical outcomes and possibly graft survival. Proteomic and genomic have been utilized in this area with some success, along with a growing discoveries of cytokines surrogate makers.
Summary:
The discovery of surrogate biomarkers in kidney transplantation is an evolving field of crucial importance that may change the way we practice transplant nephrology in the future.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Kidney Transplant I: Introduction
Serum Studies: Renal Function Tests
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction